Skip to main content

Table 2 Post vaccination sequential anti HBsAb titers in different groups

From: Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine

Stages

Mean ± SD in group 1A patient

Mean ± SD in group 1B patients

Mean ± SD in group II normal controls

Baseline B

0.00 ± 0.00

0.00 ± 0.00

0.00 ± 0.00

Before 2nd dose (C)

205 ± 613

1 ± 4

0.00 ± 0.00

After 2nd dose (D)

1181 ± 2912

26 ± 49

118 ± 397

Before 3rd dose (E)

524 ± 1478

40 ± 90

225 ± 317

After 3rd dose (F)

8834 ± 14136

462 ± 814

16906 ± 21301

Statistical Significance

p

p

p

 

B/C > 0.05,

BD < 0.05

B/C > 0.05

B/D > 0.05

B/C > 0.05

B/D > 0.05

 

B/E > 0.05

B/F < 0.01*

B/E > 0.05

B/F < 0.05

B/E < 0.01*

B/F < 0.01*